Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2025-02-13Clinical Trial Update: Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors [EARLY_Phase 1]
Early-phase Phase 1 trial evaluating allogeneic B7H3 CAR-γδT cell therapy for advanced solid tumors and ovarian cancer; not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers [NA]
This entry reports on the development of a clinical and biological database for ovarian, fallopian tube, and peritoneal cancers, sponsored b…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer [Phase 3]
Phase 3 clinical trial comparing nab-paclitaxel with solvent-based taxanes as first-line therapy for advanced ovarian cancer is currently re…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of surgery with maintenance targeted therapy for advanced ovarian cancer is currently recr…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) [Phase 3]
Phase 3 clinical trial SUNNY compares upfront surgery to neoadjuvant chemotherapy in advanced ovarian cancer. The study is currently active …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer [Phase 1]
Phase 1 clinical trial of a microdevice for ovarian, fallopian tube, and peritoneal cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of SL-172154 (SIRPα-Fc-CD40L) in ovarian, fallopian tube, and primary peritoneal cancers has completed enrollment and posted r…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue [NA]
A clinical trial is evaluating Cold Atmospheric Plasma (CAP), specifically J-Plasma, for peritoneal tumor tissue. The study is currently rec…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) [Phase 2]
A Phase 2 trial called Newton (NEW Dosing Maintenance Therapy Ovarian Cancer) sponsored by the Mario Negri Institute has been terminated. Th…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: KORE-INNOVATION: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients with Ovarian Cancer [NA]
A completed multi-site trial evaluating a perioperative care pathway to reduce complications in patients with ovarian cancer and related gyn…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update for JSKN003 in platinum-resistant, relapsed epithelial ovarian cancer; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluates Fluzoparib with or without Bevacizumab as neoadjuvant therapy for advanced ovarian cancer, with recruitme…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [EARLY_Phase 1]
An early-phase study evaluating epacadostat given before surgery in newly diagnosed, advanced ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating Avatar-Directed Chemotherapy for recurrent fallopian tube cancer, ovarian cancer, and primary peritoneal c…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT
Clinical trial update from Turku University Hospital evaluating how PET/CT staging correlates with chemotherapy response in epithelial ovari…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI)
Clinical trial update for the OPSI study evaluating post-splenectomy infections following surgery for peritoneal malignancies. The study is …
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
This clinical trial update reports completion of a study investigating homologous recombination in ovarian cancers, including ovarian cancer…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: HOT: HIPEC in Ovarian Cancer as Initial Treatment [Phase 2]
Phase 2 trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) as initial treatment for Stage III/IV ovarian cancer is currently…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients [Phase 3]
Phase 3 trial update evaluating maintenance therapy with rucaparib after bevacizumab maintenance following carboplatin-based first-line chem…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
This document provides an update on a Phase 1 trial evaluating autologous CAR T cells in patients with advanced, platinum-resistant ovarian,…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of Maplirpacept in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer was terminated, …
-
EMA withdrawal · 2024-10-24EMA Withdrawn: Onbevzi (bevacizumab) — Samsung Bioepis NL B.V.
The EMA has withdrawn the marketing authorization for Onbevzi (bevacizumab) by Samsung Bioepis NL B.V., across multiple cancer indications. …
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of ruxolitinib phosphate in combination with paclitaxel and carboplatin for S…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating the P53MVA vaccine with pembrolizumab for recurrent platinum-resistant ovarian cancer, fallopian tube cancer, or pr…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer [Phase 1]
A Phase 1 trial assessing the safety and biological activity of IP IMNN-001 (GEN-1) with neoadjuvant chemotherapy in epithelial ovarian canc…